Gliknik's Series A - III Round

Gliknik raised a round of funding on June 18, 2010. Investors include Maryland Health Care Product Development Corporation.

Gliknik is a privately held biopharmaceutical company creating new therapies for patients with cancer and immune disorders. Gliknik specializes in the modulation of the immune system to fight disease.…

Articles about Gliknik's Series A - III Round: